title: Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains.
authors.affiliation: National Centre of Influenza, Valladolid, Spain. jbermejo@hcuv.sacyl.es
authors.forename: Jesús F
authors.initials: JF
authors.lastname: Bermejo-Martin
authors.forename: David J
authors.initials: DJ
authors.lastname: Kelvin
authors.forename: Jose María
authors.initials: JM
authors.lastname: Eiros
authors.forename: Javier
authors.initials: J
authors.lastname: Castrodeza
authors.forename: Raúl
authors.initials: R
authors.lastname: Ortiz de Lejarazu
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D018942:Macrolides / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides